Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

SVM launches hedge fund partnership with Level E Capital

Monday, February 06, 2012

Melville Bucher
Opalesque Industry Update - SVM Asset Management, the Edinburgh based investment boutique, has launched a strategic partnership with Level E Capital, the Edinburgh based hedge fund.

SVM Asset Management has made a significant level of investment in the Maya Market Neutral fund, a long short absolute return fund, through the SVM Global fund.

The Maya Market Neutral fund, which launched in early January, is a systematic, long short equity fund investing in large cap UK and US equities. The fund has a liquid, diversified portfolio of 400 positions, an average gross exposure of 200% and a target return of 15%, with a market correlation of less than 0.5.

The Maya Market Neutral fund uses a fully automated decision making process. The investment methodology relies on the trading system’s ability to retrieve, store and process large quantities of data automatically, removing human subjective factors from the process.

Melville Bucher, Head of Hedge Fund marketing, SVM Asset Management, says:
“Our confidence in both Level E and the process which the Maya Market Neutral fund uses is demonstrated by the significant investment which we have made through the SVM Global fund. We believe the absolute return approach complements SVM Global fund’s existing portfolio of investments. The strategy provides the potential for equity type returns whilst also offering low volatility coupled with low correlation to traditional equity indices.

“SVM is currently the lead institutional investor in the fund and will be working in partnership with Level E promoting and distributing the product to increase the fund’s asset base.”

Sonia Schulenburg, CEO, Level E Capital, says:
“The investment team are very much looking forward to working with SVM on this fund. We have considerable knowledge and expertise in the field of artificial intelligence for securities trading and are pleased to be partnering with SVM in this venture.”

The fund offers three share classes, A, B and C. The management fees are 1% for A, 2% for B and 0.5% for C shares while the performance fees are 10% for A, 20% for B and 30% for C shares.

Minimum investment is £1 million (A) and £75,000 (B and C). Target investors are institutions, high net worth individuals, family offices and foundations.

(press release)

SVM Asset Management was founded in 1990 and is a privately owned boutique investment company based in Edinburgh. It manages assets for both retail and institutional clients and products include investment trusts, pension funds, OEICS and hedge funds. www.svmonline.co.uk

BG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its